Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial

Marja A Heiskanen, Kumail K Motiani, Andrea Mari, Virva Saunavaara, Jari-Joonas Eskelinen, Kirsi A Virtanen, Mikko Koivumäki, Eliisa Löyttyniemi, Pirjo Nuutila, Kari K Kalliokoski, Jarna C Hannukainen, Marja A Heiskanen, Kumail K Motiani, Andrea Mari, Virva Saunavaara, Jari-Joonas Eskelinen, Kirsi A Virtanen, Mikko Koivumäki, Eliisa Löyttyniemi, Pirjo Nuutila, Kari K Kalliokoski, Jarna C Hannukainen

Abstract

Aims/hypothesis: Pancreatic fat accumulation may contribute to the development of beta cell dysfunction. Exercise training improves whole-body insulin sensitivity, but its effects on pancreatic fat content and beta cell dysfunction are unclear. The aim of this parallel-group randomised controlled trial was to evaluate the effects of exercise training on pancreatic fat and beta cell function in healthy and prediabetic or type 2 diabetic participants and to test whether the responses were similar regardless of baseline glucose tolerance.

Methods: Using newspaper announcements, a total of 97 sedentary 40-55-year-old individuals were assessed for eligibility. Prediabetes (impaired fasting glucose and/or impaired glucose tolerance) and type 2 diabetes were defined by ADA criteria. Of the screened candidates, 28 healthy men and 26 prediabetic or type 2 diabetic men and women met the inclusion criteria and were randomised into 2-week-long sprint interval or moderate-intensity continuous training programmes in a 1:1 allocation ratio using random permuted blocks. The primary outcome was pancreatic fat, which was measured by magnetic resonance spectroscopy. As secondary outcomes, beta cell function was studied using variables derived from OGTT, and whole-body insulin sensitivity and pancreatic fatty acid and glucose uptake were measured using positron emission tomography. The measurements were carried out at the Turku PET Centre, Finland. The analyses were based on an intention-to-treat principle. Given the nature of the intervention, blinding was not applicable.

Results: At baseline, the group of prediabetic or type 2 diabetic men had a higher pancreatic fat content and impaired beta cell function compared with the healthy men, while glucose and fatty acid uptake into the pancreas was similar. Exercise training decreased pancreatic fat similarly in healthy (from 4.4% [3.0%, 6.1%] to 3.6% [2.4%, 5.2%] [mean, 95% CI]) and prediabetic or type 2 diabetic men (from 8.7% [6.0%, 11.9%] to 6.7% [4.4%, 9.6%]; p = 0.036 for time effect) without any changes in pancreatic substrate uptake (p ≥ 0.31 for time effect in both insulin-stimulated glucose and fasting state fatty acid uptake). In prediabetic or type 2 diabetic men and women, both exercise modes similarly improved variables describing beta cell function.

Conclusions/interpretation: Two weeks of exercise training improves beta cell function in prediabetic or type 2 diabetic individuals and decreases pancreatic fat regardless of baseline glucose tolerance. This study shows that short-term training efficiently reduces ectopic fat within the pancreas, and exercise training may therefore reduce the risk of type 2 diabetes.

Trial registration: ClinicalTrials.gov NCT01344928 FUNDING: This study was funded by the Emil Aaltonen Foundation, the European Foundation for the Study of Diabetes, the Finnish Diabetes Foundation, the Orion Research Foundation, the Academy of Finland (grants 251399, 256470, 281440, and 283319), the Ministry of Education of the State of Finland, the Paavo Nurmi Foundation, the Novo Nordisk Foundation, the Finnish Cultural Foundation, the Hospital District of Southwest Finland, the Turku University Foundation, and the Finnish Medical Foundation.

Keywords: Beta cell function; Exercise training; High-intensity interval training; Moderate-intensity continuous training; Pancreatic fat content; Pancreatic metabolism; Prediabetes; Type 2 diabetes.

Conflict of interest statement

The authors declare that there is no duality of interest associated with this manuscript.

Figures

Fig. 1
Fig. 1
Participant flow diagram. The analyses were carried out using intention-to-treat principle and hence included all the randomised participants. T2DM, type 2 diabetes mellitus
Fig. 2
Fig. 2
Pancreatic fat content in healthy and prediabetic or type 2 diabetic men at baseline (a), before and after the training intervention when participants were grouped into healthy and prediabetic or type 2 diabetic men (b), and before and after the training intervention when men were grouped according to low (≤6.2%) and high (>6.2%) pancreatic fat at baseline (c). The shaded area in (a) denotes normal pancreatic fat content (≤6.2%). (b, c) Square root transformation was performed to calculate model-based means and 95% CI. Circles, healthy men; squares, prediabetic men; triangles, type 2 diabetic men; white symbols, before exercise intervention; black symbols, after exercise intervention. T2DM, type 2 diabetes mellitus. *p ≤ 0.05, ***p ≤ 0.001 for baseline difference between the groups; †p ≤ 0.05 for time effect; ‡‡‡p ≤ 0.001 time effect for men with high pancreatic fat content
Fig. 3
Fig. 3
ISR (a) and potentiation (b) during 2 h OGTTs in healthy and prediabetic or type 2 diabetic men before and after the training intervention. The shaded area in (a) denotes ISRearly (0–30 min), which increased only in healthy men (p = 0.006 for the time effect in healthy men). There were non-significant differences in the potentiation of insulin secretion between prediabetic or type 2 diabetic men and healthy men (p = 0.083 for time effect for the potentiation factor ratio in prediabetic or type 2 diabetic men). White circles, healthy men before the exercise intervention; black circles, healthy men after the exercise intervention; white squares, prediabetic or type 2 diabetic men before the exercise intervention; black squares, prediabetic or type 2 diabetic men after the exercise intervention

References

    1. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav. 2008;94:231–241. doi: 10.1016/j.physbeh.2007.11.049.
    1. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2:901–910. doi: 10.1016/S2213-8587(14)70032-4.
    1. Guglielmi V, Sbraccia P (2017) Type 2 diabetes: does pancreatic fat really matter? Diabetes Metab Res Rev. 10.1002/dmrr.2955
    1. Catanzaro R, Cuffari B, Italia A, Marotta F (2016) Exploring the metabolic syndrome: nonalcoholic fatty pancreas disease. World J Gastroenterol 22:7660–7675
    1. Heber SD, Hetterich H, Lorbeer R, et al. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease. PLoS One. 2017;12:1–13. doi: 10.1371/journal.pone.0177154.
    1. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes. 2007;30:2916–2921.
    1. Gaborit B, Abdesselam I, Kober F, et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes. 2015;39:480–487. doi: 10.1038/ijo.2014.126.
    1. Dong Z, Luo Y, Cai H, et al. Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes. Med. 2016;95:e3858. doi: 10.1097/MD.0000000000003858.
    1. Steven S, Hollingsworth KG, Small PK, et al. Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care. 2016;39:158–165. doi: 10.2337/dc15-0750.
    1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–846. doi: 10.1038/nature05482.
    1. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46:3–19. doi: 10.1007/s00125-002-1009-0.
    1. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclearmagnetic resonance study. Diabetes Metab Res Rev. 2010;26:200–205. doi: 10.1002/dmrr.1073.
    1. Wong VW-S, Wong GL, Yeung DK et al (2014) Fatty pancreas,Insulin resistance, and β-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol 109:589–597
    1. Staaf J, Labmayr V, Paulmichl K et al (2017) Pancreatic fat is associated with metabolic syndrome and visceral fat but not beta-cell function or body mass index in pediatric obesity. Pancreas 46:358–365
    1. Begovatz P, Koliaki C, Weber K, et al. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia. 2015;58:1646–1655. doi: 10.1007/s00125-015-3544-5.
    1. Colberg S, Albright A, Blissmer B et al (2010) Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Med Sci Sports Exerc 42:2282–2303
    1. Madsen SM, Thorup AC, Overgaard K, Jeppesen PB. High intensity interval training improves glycaemic control and pancreatic β cell function of type 2 diabetes patients. PLoS One. 2015;10:1–24.
    1. Malin SK, Solomon TPJ, Blaszczak A, et al. Pancreatic β-cell function increases in a linear dose-response manner following exercise training in adults with prediabetes. AJP Endocrinol Metab. 2013;305:E1248–E1254. doi: 10.1152/ajpendo.00260.2013.
    1. Nieuwoudt S, Fealy CE, Foucher JA et al (2017) Functional high intensity training improves pancreatic β-cell function in adults with type 2 diabetes. Am J Physiol - Endocrinol Metab 313:E314–E320
    1. Solomon TPJ, Malin SK, Karstoft K, et al. Pancreatic β-cell function is a stronger predictor of changes in glycemic control after an aerobic exercise intervention than insulin sensitivity. J Clin Endocrinol Metab. 2013;98:4176–4186. doi: 10.1210/jc.2013-2232.
    1. Slentz CA, Tanner CJ, Bateman LA et al (2009) Effects of exercise training intensity on pancreatic β-cell function. Diabetes Care 32:1807–1811
    1. Singh RG, Yoon HD, Poppitt SD et al (2017) Ectopic fat accumulation in the pancreas and its clinical relevance: a systematic review, meta- analysis, and meta-regression. Metabolism 69:1–13
    1. Honkala SM, Motiani KK, Eskelinen J-J, et al. Exercise training reduces intrathoracic fat regardless of defective glucose tolerance. Med Sci Sport Exerc. 2017;49:1313–1322. doi: 10.1249/MSS.0000000000001232.
    1. Eskelinen J-J, Heinonen I, Löyttyniemi E, et al. Muscle-specific glucose and free fatty acid uptake after sprint interval and moderate-intensity training in healthy middle-aged men. J Appl Physiol. 2015;118:1172–1180. doi: 10.1152/japplphysiol.01122.2014.
    1. Sjöros T, Heiskanen MA, Motiani KK, et al. Increased insulin-stimulated glucose uptake in both leg and arm muscles after sprint interval and moderate intensity training in subjects with Type 2 Diabetes or Prediabetes. Scand J Med Sci Sport. 2018;28:77–87. doi: 10.1111/sms.12875.
    1. Heiskanen MA, Leskinen T, Eskelinen J-J et al (2015) Different predictors of right and left ventricular metabolism in healthy middle-aged men. Front Physiol 6:389
    1. Heiskanen MA, Leskinen T, Heinonen IH, et al. Right ventricular metabolic adaptations to high-intensity interval and moderate-intensity continuous training in healthy middle-aged men. Am J Physiol Heart Circ Physiol. 2016;311:H667–H675. doi: 10.1152/ajpheart.00399.2016.
    1. Heiskanen MA, Sjöros TJ, Heinonen IHA, et al. Sprint interval training decreases left-ventricular glucose uptake compared to moderate-intensity continuous training in subjects with type 2 diabetes or prediabetes. Sci Rep. 2017;7:10531. doi: 10.1038/s41598-017-10931-9.
    1. Eskelinen J-J, Heinonen I, Löyttyniemi E et al (2016) Left-ventricular vascular and metabolic adaptations to high-intensity interval and moderate intensity continuous training: a randomized trial in healthy middle-aged men. J Physiol 594:7127–7140
    1. Honkala SM, Johansson J, Motiani KK et al (2017) Short-term interval training alters brain glucose metabolism in subjects with insulin resistance. J Cereb Blood Flow Metab. 10.1177/0271678X17734998
    1. Kiviniemi AM, Tulppo MP, Eskelinen JJ, et al. Cardiac autonomic function and high-intensity interval training in middle-age men. Med Sci Sports Exerc. 2014;46:1960–1967. doi: 10.1249/MSS.0000000000000307.
    1. American Diabetes Association (2015) 2. Classification and diagnosis of diabetes. Diabetes Care 38:S8–S16
    1. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377
    1. Mari A, Schmitz O, Gastaldelli A, et al. Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002;283:E1159–E1166. doi: 10.1152/ajpendo.00093.2002.
    1. Saisho Y, Butler AE, Meier JJ, et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat. 2007;20:933–942. doi: 10.1002/ca.20543.
    1. Ferrannini E, Gastaldelli A, Miyazaki Y et al (2005) β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493–500
    1. Kanat M, Mari A, Norton L, et al. Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes. 2012;61:447–453. doi: 10.2337/db11-0995.
    1. Hannukainen JC, Borra R, Linderborg K, et al. Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol. 2011;54:545–552. doi: 10.1016/j.jhep.2010.07.029.
    1. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and β-cell function. Best Pract Res Clin Endocrinol Metab. 2003;17:305–322. doi: 10.1016/S1521-690X(03)00042-3.
    1. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663–1672. doi: 10.2337/diab.42.11.1663.
    1. Boland BB, Rhodes CJ, Grimsby JS. The dynamic plasticity of insulin production in β-cells. Mol Metab. 2017;6:958–973. doi: 10.1016/j.molmet.2017.04.010.
    1. Mari A, Tura A, Gastaldelli A, Ferrannini E. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes. 2002;51(Suppl 1):S221–S226. doi: 10.2337/diabetes.51.2007.S221.
    1. Milanović Z, Sporiš G, Weston M. Effectiveness of High-Intensity Interval Training (HIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. Sport Med. 2015;45:1469–1481. doi: 10.1007/s40279-015-0365-0.
    1. Jelleyman C, Yates T, O’Donovan G, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: A meta-analysis. Obes Rev. 2015;16:942–961. doi: 10.1111/obr.12317.
    1. Cassidy S, Thoma C, Houghton D, Trenell MI. High-intensity interval training: a review of its impact on glucose control and cardiometabolic health. Diabetologia. 2017;60:7–23. doi: 10.1007/s00125-016-4106-1.
    1. Macauley M, Percival K, Thelwall PE, et al. Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One. 2015;10:1–14. doi: 10.1371/journal.pone.0126825.
    1. Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–2514. doi: 10.1007/s00125-011-2204-7.

Source: PubMed

3
Abonnere